641 related articles for article (PubMed ID: 27382982)
1. Epigenetic Modifications and Therapy in Multiple Sclerosis.
Aslani S; Jafari N; Javan MR; Karami J; Ahmadi M; Jafarnejad M
Neuromolecular Med; 2017 Mar; 19(1):11-23. PubMed ID: 27382982
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics of multiple sclerosis: an updated review.
Küçükali Cİ; Kürtüncü M; Çoban A; Çebi M; Tüzün E
Neuromolecular Med; 2015 Jun; 17(2):83-96. PubMed ID: 24652042
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic alterations underlying autoimmune diseases.
Aslani S; Mahmoudi M; Karami J; Jamshidi AR; Malekshahi Z; Nicknam MH
Autoimmunity; 2016; 49(2):69-83. PubMed ID: 26761426
[TBL] [Abstract][Full Text] [Related]
4. The tale of histone modifications and its role in multiple sclerosis.
He H; Hu Z; Xiao H; Zhou F; Yang B
Hum Genomics; 2018 Jun; 12(1):31. PubMed ID: 29933755
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics in Multiple Sclerosis.
Chan VS
Adv Exp Med Biol; 2020; 1253():309-374. PubMed ID: 32445101
[TBL] [Abstract][Full Text] [Related]
6. An Updated Review of Epigenetic-Related Mechanisms and their Contribution to Multiple Sclerosis Disease.
Eslahi M; Nematbakhsh N; Dastmalchi N; Teimourian S; Safaralizadeh R
CNS Neurol Disord Drug Targets; 2023; 22(3):381-393. PubMed ID: 35043771
[TBL] [Abstract][Full Text] [Related]
7. Critical Link Between Epigenetics and Transcription Factors in the Induction of Autoimmunity: a Comprehensive Review.
Wu H; Zhao M; Yoshimura A; Chang C; Lu Q
Clin Rev Allergy Immunol; 2016 Jun; 50(3):333-44. PubMed ID: 26969025
[TBL] [Abstract][Full Text] [Related]
8. The epigenetic mechanism for discordance of autoimmunity in monozygotic twins.
Xiang Z; Yang Y; Chang C; Lu Q
J Autoimmun; 2017 Sep; 83():43-50. PubMed ID: 28412046
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic changes in neurology: DNA methylation in multiple sclerosis.
Iridoy Zulet M; Pulido Fontes L; Ayuso Blanco T; Lacruz Bescos F; Mendioroz Iriarte M
Neurologia; 2017 Sep; 32(7):463-468. PubMed ID: 25976949
[TBL] [Abstract][Full Text] [Related]
10. Molecular Genetic and Epigenetic Basis of Multiple Sclerosis.
Hojati Z
Adv Exp Med Biol; 2017; 958():65-90. PubMed ID: 28093709
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics in autoimmune diseases: Pathogenesis and prospects for therapy.
Zhang Z; Zhang R
Autoimmun Rev; 2015 Oct; 14(10):854-63. PubMed ID: 26026695
[TBL] [Abstract][Full Text] [Related]
12. Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis.
Koch MW; Metz LM; Kovalchuk O
Trends Mol Med; 2013 Jan; 19(1):23-30. PubMed ID: 23153574
[TBL] [Abstract][Full Text] [Related]
13. The potential role of epigenetic modifications in the heritability of multiple sclerosis.
Zhou Y; Simpson S; Holloway AF; Charlesworth J; van der Mei I; Taylor BV
Mult Scler; 2014 Feb; 20(2):135-40. PubMed ID: 24493701
[TBL] [Abstract][Full Text] [Related]
14. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity.
Long H; Yin H; Wang L; Gershwin ME; Lu Q
J Autoimmun; 2016 Nov; 74():118-138. PubMed ID: 27396525
[TBL] [Abstract][Full Text] [Related]
15. Epigenetics in Multiple Sclerosis: Molecular Mechanisms and Dietary Intervention.
Rito Y; Torre-Villalvazo I; Flores J; Rivas V; Corona T
Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):8-15. PubMed ID: 26915659
[TBL] [Abstract][Full Text] [Related]
16. Genomic imprinting: A missing piece of the Multiple Sclerosis puzzle?
Ruhrmann S; Stridh P; Kular L; Jagodic M
Int J Biochem Cell Biol; 2015 Oct; 67():49-57. PubMed ID: 26002250
[TBL] [Abstract][Full Text] [Related]
17. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
Chistiakov DA; Orekhov AN; Bobryshev YV
Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic insights into multiple sclerosis disease progression.
Kular L; Jagodic M
J Intern Med; 2020 Jul; 288(1):82-102. PubMed ID: 32614160
[TBL] [Abstract][Full Text] [Related]
19. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic modifications in prostate cancer.
Ngollo M; Dagdemir A; Karsli-Ceppioglu S; Judes G; Pajon A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon DJ
Epigenomics; 2014; 6(4):415-26. PubMed ID: 25333850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
